189 related articles for article (PubMed ID: 12414758)
1. Streptokinase promotes development of dipeptidyl peptidase IV (CD26) autoantibodies after fibrinolytic therapy in myocardial infarction patients.
Cuchacovich M; Gatica H; Vial P; Yovanovich J; Pizzo SV; Gonzalez-Gronow M
Clin Diagn Lab Immunol; 2002 Nov; 9(6):1253-9. PubMed ID: 12414758
[TBL] [Abstract][Full Text] [Related]
2. Heat shock protein and gliadin peptide promote development of peptidase antibodies in children with autism and patients with autoimmune disease.
Vojdani A; Bazargan M; Vojdani E; Samadi J; Nourian AA; Eghbalieh N; Cooper EL
Clin Diagn Lab Immunol; 2004 May; 11(3):515-24. PubMed ID: 15138176
[TBL] [Abstract][Full Text] [Related]
3. Characterization of human serum dipeptidyl peptidase IV (CD26) and analysis of its autoantibodies in patients with rheumatoid arthritis and other autoimmune diseases.
Cuchacovich M; Gatica H; Pizzo SV; Gonzalez-Gronow M
Clin Exp Rheumatol; 2001; 19(6):673-80. PubMed ID: 11791639
[TBL] [Abstract][Full Text] [Related]
4. Anti-tumor necrosis factor-alpha therapy augments dipeptidyl peptidase IV activity and decreases autoantibodies to GRP78/BIP and phosphoglucose isomerase in patients with rheumatoid arthritis.
Mavropoulos JC; Cuchacovich M; Llanos C; Aguillón JC; Gatica H; Pizzo SV; Gonzalez-Gronow M
J Rheumatol; 2005 Nov; 32(11):2116-24. PubMed ID: 16265688
[TBL] [Abstract][Full Text] [Related]
5. Infections, toxic chemicals and dietary peptides binding to lymphocyte receptors and tissue enzymes are major instigators of autoimmunity in autism.
Vojdani A; Pangborn JB; Vojdani E; Cooper EL
Int J Immunopathol Pharmacol; 2003; 16(3):189-99. PubMed ID: 14611720
[TBL] [Abstract][Full Text] [Related]
6. Anti-CD26 autoantibodies are involved in rheumatoid arthritis and show potential clinical interest.
Cordero OJ; Varela-Calviño R; López-González T; Grujic M; Juranic Z; Mouriño C; Hernández-Rodríguez Í; Rodríguez-López M; de la Iglesia BA; Pego-Reigosa JM
Clin Biochem; 2017 Nov; 50(16-17):903-910. PubMed ID: 28599787
[TBL] [Abstract][Full Text] [Related]
7. Analysis of autoantibodies to plasminogen in the serum of patients with rheumatoid arthritis.
Gonzalez-Gronow M; Cuchacovich M; Grigg DM; Pizzo SV
J Mol Med (Berl); 1996 Aug; 74(8):463-9. PubMed ID: 8872860
[TBL] [Abstract][Full Text] [Related]
8. Anti-streptokinase titers and response to streptokinase treatment in Pakistani patients.
Kazmi KA; Perwaiz Iqbal M; Rahbar A; Mehboobali N
Int J Cardiol; 2002 Mar; 82(3):247-51. PubMed ID: 11911912
[TBL] [Abstract][Full Text] [Related]
9. Does intravenous streptokinase therapy facilitate the formation of anti-heart antibodies in acute myocardial infarction?
Scolozzi R; Boccafogli A; Vicentini L; Masotti M; Baraldi A; Pradella A; Baggioni GF; Camerani A; Boniotti A
Riv Eur Sci Med Farmacol; 1989 Aug; 11(4):297-300. PubMed ID: 2640051
[TBL] [Abstract][Full Text] [Related]
10. Neutralising antibodies after streptokinase treatment for myocardial infarction: a persisting puzzle.
McGrath K; Hogan C; Hunt D; O'Malley C; Green N; Dauer R; Dalli A
Br Heart J; 1995 Aug; 74(2):122-3. PubMed ID: 7546988
[TBL] [Abstract][Full Text] [Related]
11. [Anti-streptokinase antibodies].
Helft G; Lecompte T; Le Feuvre C; Metzger JP; Vacheron A; Samama MM
Arch Mal Coeur Vaiss; 1997 Jul; 90(7):975-80. PubMed ID: 9339259
[TBL] [Abstract][Full Text] [Related]
12. Levels of dipeptidyl peptidase IV/CD26 substrates neuropeptide Y and vasoactive intestinal peptide in rheumatoid arthritis patients.
Buljevic S; Detel D; Pucar LB; Mihelic R; Madarevic T; Sestan B; Varljen J
Rheumatol Int; 2013 Nov; 33(11):2867-74. PubMed ID: 23864142
[TBL] [Abstract][Full Text] [Related]
13. Streptokinase-induced hypotension has no detrimental effect on patients with thrombolytic treatment for acute myocardial infarction. A substudy of the Romanian Study for Accelerated Streptokinase in Acute Myocardial Infarction (ASK-ROMANIA).
Tatu-Chiţoiu G; Teodorescu C; Dan M; Guran M; Căpraru P; Istrăţescu O; Tatu-Chiţoiu A; Bumbu A; Chioncel V; Arvanitopol S; Dorobanţu M
Rom J Intern Med; 2004; 42(3):557-73. PubMed ID: 16366130
[TBL] [Abstract][Full Text] [Related]
14. Cross-talk between the dipeptidyl peptidase-4 and stromal cell-derived factor-1 in stem cell homing and myocardial repair: Potential impact of dipeptidyl peptidase-4 inhibitors.
Anderluh M; Kocic G; Tomovic K; Kocic R; Deljanin-Ilic M; Smelcerovic A
Pharmacol Ther; 2016 Nov; 167():100-107. PubMed ID: 27484974
[TBL] [Abstract][Full Text] [Related]
15. Association of CD26/dipeptidyl peptidase IV mRNA level in peripheral blood mononuclear cells with disease activity and bone erosion in rheumatoid arthritis.
Yeganeh F; Mousavi SMJ; Hosseinzadeh-Sarband S; Ahmadzadeh A; Bahrami-Motlagh H; Hoseini MHM; Sattari M; Sohrabi MR; Pouriran R; Dehghan P
Clin Rheumatol; 2018 Dec; 37(12):3183-3190. PubMed ID: 30136129
[TBL] [Abstract][Full Text] [Related]
16. CD26/dipeptidyl-peptidase IV and adenosine deaminase serum levels in psoriatic patients treated with cyclosporine, etanercept, and psoralen plus ultraviolet A phototherapy.
Yıldırım FE; Karaduman A; Pinar A; Aksoy Y
Int J Dermatol; 2011 Aug; 50(8):948-55. PubMed ID: 21781066
[TBL] [Abstract][Full Text] [Related]
17. Clinical usefulness of a functional test of neutralising streptokinase antibodies for the prediction of the thrombolytic effect of streptokinase in acute myocardial infarction.
Gill S; Kristensen SR; Haastrup B; Haghfelt T
Cardiology; 2003; 100(1):36-40. PubMed ID: 12975544
[TBL] [Abstract][Full Text] [Related]
18. Caveolin-1, a binding protein of CD26, is essential for the anti-inflammatory effects of dipeptidyl peptidase-4 inhibitors on human and mouse macrophages.
Hiromura M; Nohtomi K; Mori Y; Kataoka H; Sugano M; Ohnuma K; Kuwata H; Hirano T
Biochem Biophys Res Commun; 2018 Jan; 495(1):223-229. PubMed ID: 29113797
[TBL] [Abstract][Full Text] [Related]
19. CD26/dipeptidyl peptidase IV: a regulator of immune function and a potential molecular target for therapy.
Aytac U; Dang NH
Curr Drug Targets Immune Endocr Metabol Disord; 2004 Mar; 4(1):11-8. PubMed ID: 15032621
[TBL] [Abstract][Full Text] [Related]
20. Dipeptidyl peptidase IV (DPP IV, CD26) in patients with mental eating disorders.
Hildebrandt M; Rose M; Mayr C; Arck P; Schüler C; Reutter W; Salama A; Klapp BF
Adv Exp Med Biol; 2000; 477():197-204. PubMed ID: 10849747
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
